Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-25 Sale |
2021-05-27 5:42 pm |
Jounce Therapeutics Inc. | JNCE | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner |
552,520 | $8 | $4,420,160 | 9,387,176 (Indirect Direct) |
View |
| 2021-04-15 Sale |
2021-04-16 8:46 pm |
Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director |
200 | $10 | $2,000 | 9,713 (Direct) |
View |
| 2021-03-29 Sale |
2021-03-31 8:22 pm |
Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer |
13,500 | $10.09 | $136,206 | 721,940 (Direct) |
View |
| 2021-03-15 Sale |
2021-03-17 9:15 pm |
Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director |
200 | $12.8 | $2,560 | 9,913 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 6:00 pm |
Jounce Therapeutics Inc. | JNCE | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner |
1,450,000 | $11.75 | $17,037,500 | 10,960,405 (Indirect Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 7:47 pm |
Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director |
200 | $11.78 | $2,356 | 10,113 (Direct) |
View |
| 2021-01-21 Sale |
2021-01-25 5:38 pm |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
33,518 | $12.06 | $404,227 | 805,540 (Direct) |
View |
| 2021-01-22 Sale |
2021-01-25 5:36 pm |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
18,000 | $11.95 | $215,100 | 141,689 (Direct) |
View |
| 2021-01-20 Sale |
2021-01-22 6:40 pm |
Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer |
6,500 | $12.01 | $78,065 | 78,385 (Direct) |
View |
| 2021-01-20 Sale |
2021-01-22 6:39 pm |
Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director |
1,700 | $11.9 | $20,222 | 10,313 (Direct) |
View |
| 2021-01-20 Sale |
2021-01-22 6:35 pm |
Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer |
30,000 | $11.36 | $340,786 | 458,990 (Direct) |
View |
| 2021-01-15 Sale |
2021-01-20 8:38 pm |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
86,482 | $9.6927 | $838,243 | 2,309,396 (Direct) |
View |
| 2021-01-07 Sale |
2021-01-11 06:21 am |
Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer |
5,298 | $6.8889 | $36,498 | 71,335 (Direct) |
View |
| 2021-01-07 Sale |
2021-01-11 06:21 am |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
21,999 | $6.8889 | $151,549 | 140,371 (Direct) |
View |
| 2021-01-07 Sale |
2021-01-11 06:19 am |
Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer |
5,827 | $6.8889 | $40,142 | 55,881 (Direct) |
View |
| 2021-01-07 Sale |
2021-01-11 06:19 am |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
6,219 | $6.8889 | $42,842 | 55,189 (Direct) |
View |
| 2020-11-19 Sale |
2020-11-23 4:42 pm |
Jounce Therapeutics Inc. | JNCE | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner |
15,000 | $7.005 | $105,075 | 9,361,137 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-15 Other |
2021-09-17 1:38 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director |
0 | $0 | 50,468 (Indirect) |
View |
| 2021-09-13 Option Award |
2021-09-15 08:16 am |
N/A 2031-09-13 |
Jounce Therapeutics Inc. | JNCE | Raythatha Jigar Director |
31,400 | $0 | 31,400 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 4:50 pm |
N/A 2031-06-18 |
Jounce Therapeutics Inc. | JNCE | Salter-Cid Luisa Director |
7,850 | $0 | 7,850 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 4:49 pm |
N/A 2031-06-18 |
Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 4:49 pm |
N/A 2031-06-18 |
Jounce Therapeutics Inc. | JNCE | Kamen Robert Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 4:47 pm |
N/A 2031-06-18 |
Jounce Therapeutics Inc. | JNCE | Iannone Robert Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 4:46 pm |
N/A 2031-06-18 |
Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 4:45 pm |
N/A 2031-06-18 |
Jounce Therapeutics Inc. | JNCE | Duncan Barbara Gayle Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 4:44 pm |
N/A 2031-06-18 |
Jounce Therapeutics Inc. | JNCE | Diaz Luis Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 4:34 pm |
N/A 2031-06-18 |
Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2021-06-10 Other |
2021-06-14 4:23 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director |
0 | $0 | 35,979 (Indirect) |
View |
| 2021-06-10 Other |
2021-06-14 4:19 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner |
1,500,000 | $0 | 9,647,049 (Direct) |
View |
| 2021-03-29 Exercise |
2021-03-31 8:22 pm |
N/A 2025-11-12 |
Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer |
13,500 | $0 | 721,940 (Direct) |
View |
| 2021-03-29 Exercise |
2021-03-31 8:22 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer |
13,500 | $4.02 | 721,940 (Direct) |
View |
| 2021-03-11 Other |
2021-03-15 4:15 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner |
1,250,000 | $0 | 11,189,696 (Direct) |
View |
| 2021-03-11 Other |
2021-03-15 4:15 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director |
0 | $0 | 25,066 (Indirect) |
View |
| 2021-02-10 Option Award |
2021-02-12 08:10 am |
N/A 2031-02-10 |
Jounce Therapeutics Inc. | JNCE | Salter-Cid Luisa Director |
31,400 | $0 | 31,400 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 5:50 pm |
N/A 2031-02-01 |
Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer |
66,750 | $0 | 138,085 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 5:48 pm |
N/A 2031-02-01 |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
247,500 | $0 | 387,871 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 5:46 pm |
N/A 2031-02-01 |
Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer |
66,750 | $0 | 109,931 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 5:45 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
26,700 | $0 | 127,289 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 5:45 pm |
N/A 2031-02-01 |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
53,400 | $11.89 | 127,289 (Direct) |
View |
| 2021-01-21 Exercise |
2021-01-25 5:38 pm |
N/A 2024-06-26 |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
33,518 | $0 | 805,540 (Direct) |
View |
| 2021-01-21 Exercise |
2021-01-25 5:38 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
33,518 | $0.48 | 805,540 (Direct) |
View |
| 2021-01-22 Exercise |
2021-01-25 5:36 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
5,000 | $4.4 | 141,689 (Direct) |
View |
| 2021-01-22 Exercise |
2021-01-25 5:36 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
5,000 | $6.55 | 141,689 (Direct) |
View |
| 2021-01-22 Exercise |
2021-01-25 5:36 pm |
N/A 2029-02-01 |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
10,000 | $0 | 141,689 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-22 6:40 pm |
N/A 2025-12-08 |
Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer |
6,500 | $0 | 78,385 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-22 6:40 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer |
6,500 | $4.02 | 78,385 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-22 6:35 pm |
N/A 2024-01-27 |
Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer |
17,300 | $0 | 458,990 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-22 6:35 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer |
6,775 | $0.74 | 458,990 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-22 6:35 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer |
3,016 | $0.48 | 458,990 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-22 6:35 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer |
7,509 | $2.36 | 458,990 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-20 8:38 pm |
N/A 2024-06-26 |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
86,482 | $0 | 2,309,396 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-20 8:38 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
86,482 | $0.48 | 2,309,396 (Direct) |
View |